Ambulanc (Shenzhen) Tech. Co., Ltd was established in 2001 by a group of experts in emergency care. Our brand Amoul® is dedicated to innovation and the development of comprehensive life support solutions, and manufacturing respiratory therapy, cardiopulmonary resuscitation (CPR), anesthesia, emergency care, and critical care devices.
The professional R&D team plays a pivotal role in advancing technologies for pneumatic and turbine life support ventilation, CPR, airway management, conscious sedation devices, and anesthesia machines, serving healthcare professionals and patients worldwide.
Ambulanc owns 400+ patents and CFDA medical device registration certificates for Class II and Class III medical equipment, besides a wide range of international certifications such as ISO13485, FDA (EUA), CE, MDL, TAG, etc.
Amoul® owns highly qualified R&D team, specialized in innovation, development and manufacturing of life support medical devices for critical care, respiratory, resuscitation and analgesia etc. Ambulanc invented the first conscious sedation system in China.
Ambulanc honored with 30+ CFDA medical registration certificates, 400+ patents, including over 70+ domestic invention patents and a number of international PCT invention patents.